NEWS ROOM
- 2023.09.20The Construction Plan of mRNA Therapeutics Manufacturing, Technology Development Facility has been Selected for the METI Subsidy Programs Press Release
- 2023.09.12Axcelead has selected as a finalist of the “Citeline Pharma Intelligence Awards Japan” 2023 Topics
- 2023.08.23Axcelead DDP’s Drug Discovery Support Business Honored with the 6th Japan Medical Research and Development Grand Prize Press Release
- 2023.08.04ARCALIS – Notice of Completion of New mRNA Drug Substance Plant Press Release
- 2023.07.03Teijin and Axcelead to Establish Drug Discovery Research Joint Venture Press Release